Alex CHEN M.D., Ph.D., M.Sc. in

Alex CHEN M.D., Ph.D., M.Sc.

Sharpshooter · DISC type DC
Global Director & Lead | Medical AI Strategy & Scientific Communications (Immunology) at Johnson & Johnson
📍 New York City Metropolitan Area, United States

Dr. Alex Chen is a Global Director at Johnson & Johnson, leading the enterprise-level Medical AI strategy for the immunology portfolio. A board-certified physician with a Ph. D. from Imperial College London, his leadership experience spans numerous therapeutic areas including Neuroscience and Oncology. Colleagues have described him as dynamic and detail-oriented.

Beyond his corporate role, Dr. Chen is deeply committed to medical education, serving as a Visiting Professor at Imperial College Londons Faculty of Medicine. He has a distinct interest in the human side of medicine, particularly the ethical and psychosocial aspects of organ transplantation.

He is a recipient of The Presidential Award, the highest civilian honor in Taiwan, recognizing him as one of the Top 10 Outstanding Youth.

Read the full overview →
Experience
17 Years
Current Role
Global Director & Lead | Medical AI Strategy & Scientific Communications (Immunology)
Job Level
Mid-senior
Location
New York City Metropolitan Area, United States
Personality Overview

How Alex shows up

Precise But Practical
Fast But Analytical
Rigorous & Demanding

They take a lot of pride in personal achievements. They are not always relationship oriented. They like to move fast and expect the same from others.

Priorities

Topics Alex cares about

Medical AI Strategy
He currently leads a global mandate at Johnson & Johnson to define and scale AI-driven medical and scientific strategy across the company's immunology portfolio.
Evidence-Based Medicine
He architected Johnson & Johnson’s first Medical Impact Framework and introduced a novel scientific scoring system to prioritize clinical studies, demonstrating a focus on data-driven decisions.
+5 more topics Login to view topics
Career

Work history

10-2025
Global Director & Lead | Medical AI Strategy & Scientific Communications (Immunology)
Johnson & Johnson
10-2023
Head of Medical Excellence & Impact | USA
Johnson & Johnson
1-2022 - 2-2024
Head of Integrated Evidence Strategy, and Pipeline | USA
Johnson & Johnson
7-2021
Goodwill Ambassador of United Nations-NGO | USA
STUF United Fund
4-2021
Visiting Professor, Faculty of Medicine | United Kingdom
Imperial College London
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Doctor of Philosophy (PhD)
Imperial College London
Mini MBA
Imperial College London
Social presence
in
Behavioral profile

DISC profile (public)

D

Dominance (D)

Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.

Other Johnson & Johnson Employees

Explore more public profiles from related professionals.

Mariana Fernandes Belmonte Pola
Mariana Fernandes Belmonte Pola
Customer Service Specialist
Johnson & Johnson
 Marcelo Rodrigues
Marcelo Rodrigues
Latin America Deliver and Customer Service Product Owner
Johnson & Johnson
 Rachael DiSantostefano, PhD MS FISPE
Rachael DiSantostefano, PhD MS FISPE
Senior Director, Epidemiology; Interventional Oncology Head
Johnson & Johnson
 Seema Vaidyanathan, MS, CSAP
Seema Vaidyanathan, MS, CSAP
Director Scientific Partnerships, J&J Scientific Affairs
Johnson & Johnson

More profiles

Discover additional public profiles from our index.

Emma Greenberg
Emma Greenberg
Campaign Manager
Stefany Shaheen for Congress
 Andrew Davis
Andrew Davis
Head of Analytics & Data Science
Marks and Spencer
 Biren Mehta
Biren Mehta
Vice President, Venture Investments
Johnson & Johnson
 Carolyn P.
Carolyn P.
Senior Director, Privacy, AI & Ethics and DSSPE Operations
Johnson & Johnson Innovative Medicine
Unlock the full playbookSee exactly how to sell to Alex. Free, 10 seconds.